The effect of quitting smoking on HDL-cholesterol - a review based on within-subject changes

Biomarker Research

Volumn 1, Issue 1, 2013, Pages

  Forey, Barbara A ^a   Fry, John S ^a   Lee, Peter N ^a   Thornton, Alison J ^b   Coombs, Katharine J ^a  

^a PN Lee Statistics and Computing Ltd   (United Kingdom)

^b NONE

Author keywords

HDL cholesterol; Meta analysis; Review; Smoking cessation

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; NICOTINE;

BODY MASS; BODY WEIGHT; DIET; EXERCISE; HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SMOKING CESSATION;

EID: 84977542048     PISSN: None     EISSN: 20507771     Source Type: Journal    
DOI: 10.1186/2050-7771-1-26     Document Type: Review

References (70)

1. Craig WY, Palomaki GE, Haddow JE. Cigarette smoking and serum lipid and lipoprotein concentrations: an analysis of published data. BMJ 1989, 298:784-788. 10.1136/bmj.298.6676.784, 1836079, 2496857.
2. US Surgeon General The health benefits of smoking cessation. A report of the Surgeon General: US Department of Health and Human Services, Public Health Service, Centers for Disease Control, Center for Chronic Disease Prevention and Health Promotion 1990, Rockville, Maryland: Office on Smoking and Health, DHHS Publication No. (CDC) 90-8416. http://www.surgeongeneral.gov/library/reports/index.html, US Surgeon General.
3. US Surgeon General The health consequences of smoking. A report of the Surgeon General 2004, Atlanta, Georgia: US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, http://www.surgeongeneral.gov/library/reports/index.html, US Surgeon General.
4. Maeda K, Noguchi Y, Fukui T. The effects of cessation from cigarette smoking on the lipid and lipoprotein profiles: a meta-analysis. Prev Med 2003, 37:283-290. 10.1016/S0091-7435(03)00110-5, 14507483.
5. Berlin I. Endocrine and metabolic effects of smoking cessation. Curr Med Res Opin 2009, 25:527-534. 10.1185/03007990802707626, 19205076.
6. Chelland Campbell S, Moffatt RJ, Stamford BA. Smoking and smoking cessation - the relationship between cardiovascular disease and lipoprotein metabolism: a review. Atherosclerosis 2008, 201:225-235. 10.1016/j.atherosclerosis.2008.04.046, 18565528.
7. Eapen DJ, Kalra GL, Rifai L, Eapen CA, Merchant N, Khan BV. Raising HDL cholesterol in women. Int J Womens Health 2010, 1:181-191. 2971704, 21072287.
8. Lepšanović L, Brkljač O, Lepšanović L. Uticaj pušenja na metabolizam lipoproteina (Effect of smoking on lipoprotein metabolism). Med Pregl 2001, 54:453-458.
9. Kenward MG, Roger JH. Small sample inference for fixed effects from restricted maximum likelihood. Biometrics 1997, 53:983-997. 10.2307/2533558, 9333350.
10. Littell RC, Milliken GA, Stroup WW, Wolfinger RD, Schabenberger O. SAS for Mixed Models 2006, Cary, NC: SAS Publishing, 2.
11. Moffatt RJ, Stamford A, Owens SG, Chitwood LF. Cessation from smoking: Lipoprotein changes in men and women. J Smoking-Related Disord 1992, 3:19.
12. Kondo T, Hayashi M, Takeshita K, Numaguchi Y, Kobayashi K, Iino S, Inden Y, Murohara T. Smoking cessation rapidly increases circulating progenitor cells in peripheral blood in chronic smokers. Arterioscler Thromb Vasc Biol 2004, 24:1442-1447. 10.1161/01.ATV.0000135655.52088.c5, 15191940.
13. Wang W, Chair SY, Thompson DR, Twinn SF. Effects of home-based rehabilitation on health-related quality of life and psychological status in Chinese patients recovering from acute myocardial infarction. Heart Lung 2012, 41:15-25. 10.1016/j.hrtlng.2011.05.005, 21974926.
14. Allen SS, Hatsukami D, Gorsline J. Cholesterol changes in smoking cessation using the transdermal nicotine system. Prev Med 1994, 23:190-196. 10.1006/pmed.1994.1026, 8047525.
15. Transdermal Nicotine Study Group Transdermal nicotine for smoking cessation. Six-month results from two multicenter controlled clinical trials. Transdermal Nicotine Study Group. JAMA 1991, 266:3133-3138. 10.1001/jama.1991.03470220049025, 1956099, Transdermal Nicotine Study Group.
16. Basler HD, Brinkmeier U, Buser K, Gluth G. Nicotine gum assisted group therapy in smokers with an increased risk of coronary disease - evaluation in a primary care setting format. Health Educ Res 1992, 7:87-95. 10.1093/her/7.1.87, 10148733.
17. Burnette MM, Meilahn E, Wing RR, Kuller LH. Smoking cessation, weight gain, and changes in cardiovascular risk factors during menopause: the Healthy Women Study. Am J Public Health 1998, 88:93-96. 10.2105/AJPH.88.1.93, 1508411, 9584041.
18. Wing RR, Matthews KA, Kuller LH, Meilahn EN, Plantinga PL. Weight gain at the time of menopause. Arch Intern Med 1991, 151:97-102. 10.1001/archinte.1991.00400010111016, 1985614.
19. Eliasson B, Attvall S, Taskinen MR, Smith U. Smoking cessation improves insulin sensitivity in healthy middle-aged men. Eur J Clin Invest 1997, 27:450-456. 10.1046/j.1365-2362.1997.1330680.x, 9179554.
20. Eliasson B, Hjalmarson A, Kruse E, Landfeldt B, Westin A. Effect of smoking reduction and cessation on cardiovascular risk factors. Nicotine Tob Res 2001, 3:249-255.
21. Feher MD, Rampling MW, Brown J, Robinson R, Richmond W, Cholerton S, Bain BJ, Sever PS. Acute changes in atherogenic and thrombogenic factors with cessation of smoking. J R Soc Med 1990, 83:146-148. 1292556, 2325055.
22. Bain BJ, Rothwell M, Feher MD, Robinson R, Brown J, Sever PS. Acute changes in haematological parameters on cessation of smoking. J R Soc Med 1992, 85:80-82. 1294887, 1538385.
23. Ferrara CM, Kumar M, Nicklas B, McCrone S, Goldberg AP. Weight gain and adipose tissue metabolism after smoking cessation in women. Int J Obes Relat Metab Disord 2001, 25:1322-1326. 10.1038/sj.ijo.0801716, 11571594.
24. Fortmann SP, Haskell WL, Williams PT. Changes in plasma high density lipoprotein cholesterol after changes in cigarette use. Am J Epidemiol 1986, 124:706-710.
25. Fortmann SP, Flora JA, Winkleby MA, Schooler C, Barr Taylor C, Farquhar JW. Community intervention trials: reflections on the Stanford Five-City Project experience. Am J Epidemiol 1995, 142:576-586.
26. Gepner AD, Piper ME, Johnson HM, Fiore MC, Baker TB, Stein JH. Effects of smoking and smoking cessation on lipids and lipoproteins: outcomes from a randomized clinical trial. Am Heart J 2011, 161:145-151. 10.1016/j.ahj.2010.09.023, 3110741, 21167347.
27. Piper ME, Smith SS, Schlam TR, Fiore MC, Jorenby DE, Fraser D, Baker TB. A randomized placebo-controlled clinical trial of 5 smoking cessation pharmacotherapies. Arch Gen Psychiatry 2009, 66:1253-1262. 10.1001/archgenpsychiatry.2009.142, 2933113, 19884613.
28. Johnson HM, Gossett LK, Piper ME, Aeschlimann SE, Korcarz CE, Baker TB, Fiore MC, Stein JH. Effects of smoking and smoking cessation on endothelial function: 1-year outcomes from a randomized clinical trial. J Am Coll Cardiol 2010, 55:1988-1995. 10.1016/j.jacc.2010.03.002, 2947952, 20236788.
29. Asthana A, Johnson HM, Piper ME, Fiore MC, Baker TB, Stein JH. Effects of smoking intensity and cessation on inflammatory markers in a large cohort of active smokers. Am Heart J 2010, 160:458-463. 10.1016/j.ahj.2010.06.006, 2937015, 20826253.
30. Gerace TA, Hollis J, Ockene JK, Svendsen K. Smoking cessation and change in diastolic blood pressure, body weight, and plasma lipids. Prev Med 1991, 20:602-620. 10.1016/0091-7435(91)90058-C, 1758841.
31. Multiple Risk Factor Intervention Trial Research Group (MRFIT) Multiple Risk Factor Intervention Trial. Risk factor changes and mortality results. JAMA 1982, 248:1465-1477. Multiple Risk Factor Intervention Trial Research Group (MRFIT).
32. Green MS, Harari G. A prospective study of the effects of changes in smoking habits on blood count, serum lipids and lipoproteins, body weight and blood pressure in occupationally active men. The Israeli CORDIS Study. J Clin Epidemiol 1995, 48:1159-1166. 10.1016/0895-4356(95)00005-O, 7636518.
33. Haustein K-O, Krause J, Haustein H, Rasmussen T, Cort N. Comparison of the effects of combined nicotine replacement therapy vs. cigarette smoking in males. Nicotine Tob Res 2003, 5:195-203. 10.1080/146222003100073676, 12745492.
34. Haustein K-O, Krause J, Haustein H, Rasmussen T, Cort N. Effects of cigarette smoking or nicotine replacement on cardiovascular risk factors and parameters of haemorheology. J Intern Med 2002, 252:130-139. 10.1046/j.1365-2796.2002.01014.x, 12190888.
35. Haustein K-O, Krause J, Haustein H, Rasmussen T, Cort N. Changes in hemorheological and biochemical parameters following short-term and long-term smoking cessation induced by nicotine replacement therapy (NRT). Int J Clin Pharmacol Ther 2004, 42:83-92. 10.5414/CPP42083, 15180168.
36. Iino K, Iwase M, Tsutsu N, Iida M. Smoking cessation and glycaemic control in type 2 diabetic patients. Diabetes Obes Metab 2004, 6:181-186. 10.1111/j.1462-8902.2004.00329.x, 15056125.
37. Korhonen T, Goodwin A, Miesmaa P, Dupuis EA, Kinnunen T. Smoking cessation program with exercise improves cardiovascular disease biomarkers in sedentary women. J Womens Health 2011, 20:1051-1064.
38. Kume A, Kume T, Masuda K, Shibuya F, Yamazaki H. Dose-dependent effects of cigarette smoke on blood biomarkers in healthy Japanese volunteers: observations from smoking and non-smoking. J Health Sci 2009, 55:259-264.
39. Kushima K, Takamoto N, Sato H. Munaka M: (Effect of smoking cessation on body mass index, blood pressure and serum lipids in middle-aged male workers). Nihon Koshu Eisei Zasshi 1998, 45:1000-1010.
40. Lee S-S, Seo J-S, Kim S-R, Jeong J-E, Nam B-W, Lee J-Y, Lee H-J, Lee C, Lee C-U, Paik I-H, Chae J-H, Chai S-H, Yoo S-J, Won W-Y, Kim D-J. The changes of blood glucose control and lipid profiles after short-term smoking cessation in healthy males. Psychiatry Investig 2011, 8:149-154. 10.4306/pi.2011.8.2.149, 3149110, 21852992.
41. Lúdvíksdóttir D, Blöndal T, Franzon M, Gudmundsson TV, Säwe U. Effects of nicotine nasal spray on atherogenic and thrombogenic factors during smoking cessation. J Intern Med 1999, 246:61-66. 10.1046/j.1365-2796.1999.00506.x, 10447226.
42. Blöndal T, Franzon M, Westin A. A double-blind randomized trial of nicotine nasal spray as an aid in smoking cessation. Eur Respir J 1997, 10:1585-1590. 10.1183/09031936.97.10071585, 9230252.
43. Masarei JR, Puddey IB, Vandongen R, Beilin LJ, Lynch WJ. Effect of smoking cessation on serum apolipoprotein A-I and A-II concentrations. Pathology 1991, 23:98-102. 10.3109/00313029109060805, 1745574.
44. Moffatt RJ. Effects of cessation of smoking on serum lipids and high density lipoprotein-cholesterol. Atherosclerosis 1988, 74:85-89. 10.1016/0021-9150(88)90194-3, 3214483.
45. Moffatt RJ, Biggerstaff KD, Stamford BA. Effects of the transdermal nicotine patch on normalization of HDL-C and its subfractions. Prev Med 2000, 31:148-152. 10.1006/pmed.2000.0694, 10938215.
46. Niaura R, Marcus B, Albrecht A, Thompson P, Abrams D. Exercise, smoking cessation, and short-term changes in serum lipids in women: a preliminary investigation. Med Sci Sports Exerc 1998, 30:1414-1418.
47. Nilsson P, Lundgren H, Söderström M, Fagerström K-O, Nilsson-Ehle P. Effects of smoking cessation on insulin and cardiovascular risk factors - a controlled study of 4 months' duration. J Intern Med 1996, 240:189-194. 10.1046/j.1365-2796.1996.16844000.x, 8918509.
48. Norregaard J, Jorgensen S, Mikkelsen KL, Tonnesen P, Iversen E, Sorensen T, Soeberg B, Jakobsen HB. The effect of ephedrine plus caffeine on smoking cessation and postcessation weight gain. Clin Pharmacol Ther 1996, 60:679-686. 10.1016/S0009-9236(96)90217-9, 8988071.
49. Priemé H, Nyssönen K, Grønbæk K, Klarlund M, Loft S, Tønnesen P, Salonen JT, Poulsen HE. Randomized controlled smoking cessation study: transient increase in plasma high density lipoprotein but no change in lipoprotein oxidation resistance. Scand J Clin Lab Invest 1998, 58:11-18. 10.1080/00365519850186788, 9516652.
50. Puls M, Schroeter MR, Steier J, Stijohann L, Hasenfuss G, Konstantinides S, Schäfer K. Effect of smoking cessation on the number and adhesive properties of early outgrowth endothelial progenitor cells. Int J Cardiol 2011, 152:61-69. 10.1016/j.ijcard.2010.07.007, 21093936.
51. Quensel M, Söderstrom A, Agardh CD, Nilsson-Ehle P. High density lipoprotein concentrations after cessation of smoking: the importance of alterations in diet. Atherosclerosis 1989, 75:189-193. 10.1016/0021-9150(89)90176-7, 2712863.
52. Rabkin SW. Effect of cigarette smoking cessation on risk factors for coronary atherosclerosis. Atherosclerosis 1984, 53:173-184. 10.1016/0021-9150(84)90193-X, 6517973.
53. Rahilly-Tierney C, Vokonas P, Gaziano JM, Spiro A. Lifestyle Change and High-Density Lipoprotein Change: The US Department of Veterans Affairs Normative Aging Study. Clin Cardiol 2012, 35:437-442. 10.1002/clc.21978, 22407520.
54. Richard F, Marécaux N, Dallongeville J, Devienne M, Tiem N, Fruchart JC, Fantino M, Zylberberg G, Amouyel P. Effect of smoking cessation on lipoprotein A-I and lipoprotein A-I:A-II levels. Metabolism 1997, 46:711-715. 10.1016/S0026-0495(97)90018-4, 9186310.
55. Shennan NM, Seed M, Wynn V. Variation in serum lipid and lipoprotein levels associated with changes in smoking behaviour in non-obese Caucasian males. Atherosclerosis 1985, 58:17-25. 10.1016/0021-9150(85)90052-8, 3867355.
56. Stamford BA, Matter S, Fell RD, Papanek P. Effects of smoking cessation on weight gain, metabolic rate, caloric consumption, and blood lipids. Am J Clin Nutr 1986, 43:486-494.
57. Stubbe I, Eskilsson J, Nilsson-Ehle P. High-density lipoprotein concentrations increase after stopping smoking. Br Med J 1982, 284:1511-1513.
58. Suwazono Y, Dochi M, Oishi M, Tanaka K, Morimoto H, Sakata K. Longitudinal effect of smoking cessation on physical and laboratory findings. Am J Prev Med 2010, 38:192-200. 10.1016/j.amepre.2009.09.040, 20117576.
59. Swank A, Pickering K, Ronald DF. Short-term changes in high-density lipoprotein cholesterol consequent to a seven-week smoking cessation program in women. J Cardiopulm Rehabil 1991, 11:353-359.
60. Tamura U, Tanaka T, Okamura T, Kadowaki T, Yamato H, Tanaka H, Nakamura M, Okayama A, Ueshima H, Yamagata Z. Changes in weight, cardiovascular risk factors and estimated risk of coronary heart disease following smoking cessation in Japanese male workers: HIPOP-OHP Study. J Atheroscler Thromb 2010, 17:12-20. 10.5551/jat.1800, 20081325.
61. Terres W, Becker P, Rosenberg A. Changes in cardiovascular risk profile during the cessation of smoking. Am J Med 1994, 97:242-249. 10.1016/0002-9343(94)90007-8, 8092173.
62. Tonstad S, Urdal P. Does short-term smoking cessation reduce plasma total homocysteine concentrations?. Scand J Clin Lab Invest 2002, 62:279-284. 10.1080/003655102760145834, 12476926.
63. van den Berkmortel FWPJ, Demacker PNM, Wollersheim H, Thien T, Stalenhoef AFH. Smoking or its cessation does not alter the susceptibility to in vitro LDL oxidation. Eur J Clin Invest 2000, 30:972-979. 10.1046/j.1365-2362.2000.00739.x, 11114959.
64. Yamamoto R, Kawamura T, Wakai K, Ichihara Y, Anno T, Mizuno Y, Yokoi M, Ohta T, Iguchi A, Ohno Y. Favorable life-style modification and attenuation of cardiovascular risk factors. Jpn Circ J 1999, 63:184-188. 10.1253/jcj.63.184, 10201619.
65. Yeh H-C, Duncan BB, Schmidt MI, Wang N-Y, Brancati FL. Smoking, smoking cessation, and risk for type 2 diabetes mellitus: a cohort study. Ann Intern Med 2010, 152:10-17. 10.7326/0003-4819-152-1-201001050-00005, 20048267.
66. ARIC Investigators The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators. Am J Epidemiol 1989, 129:687-702. ARIC Investigators.
67. Yoon C, Goh E, Park SM, Cho B. Effects of smoking cessation and weight gain on cardiovascular disease risk factors in Asian male population. Atherosclerosis 2010, 208:275-279. 10.1016/j.atherosclerosis.2009.07.024, 19660751.
68. Zhang P, Guo R, Xiao D, Chu S, Gong L, Zhang C, Jing B, Li M. Influence of smoking cessation on carotid artery wall elasticity evaluated by echo-tracking. J Clin Ultrasound 2012, 40:352-356. 10.1002/jcu.21920, 22508424.
69. Benowitz NL. Pharmacologic aspects of cigarette smoking and nicotine addiction. N Engl J Med 1988, 319:1318-1330. 10.1056/NEJM198811173192005, 3054551.
70. Freeman DJ, Packard CJ. Smoking and plasma lipoprotein metabolism. Clin Sci 1995, 89:333-342.